ASCO-GU 2023: ARASENS

Dr Turner undertook medical training at the University of Cambridge, graduating in 2008. He returned to his native Northern Ireland to complete postgraduate specialist training in clinical oncology. He completed his PhD as part of the advanced radiotherapy group in Queen’s University Belfast designing clinical trials investigating drug/radiotherapy combinations in advanced prostate cancer.

He was selected for an international fellowship at St George Hospital Sydney, an Australian centre of excellence for brachytherapy. He trained in the use of low and high dose rate brachytherapy techniques in a range of malignancies.

Dr Turner returned to the UK initially working as a substantive consultant in Oxford University Hospitals. He moved to Royal Surrey NHS foundation trust in 2022. He specialises in drug and radiotherapy treatment of prostate and lung cancers including brachytherapy and molecular radiotherapy.

He has published extensively and presented his work at national and international meetings on the subject of radiotherapy/radionuclide combinations and on brachytherapy.